• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系来源的抑制细胞崭露头角。

Myeloid-derived suppressor cells coming of age.

机构信息

The Wistar Institute, Philadelphia, PA, USA.

出版信息

Nat Immunol. 2018 Feb;19(2):108-119. doi: 10.1038/s41590-017-0022-x. Epub 2018 Jan 18.

DOI:10.1038/s41590-017-0022-x
PMID:29348500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5854158/
Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells generated during a large array of pathologic conditions ranging from cancer to obesity. These cells represent a pathologic state of activation of monocytes and relatively immature neutrophils. MDSCs are characterized by a distinct set of genomic and biochemical features, and can, on the basis of recent findings, be distinguished by specific surface molecules. The salient feature of these cells is their ability to inhibit T cell function and thus contribute to the pathogenesis of various diseases. In this Review, we discuss the origin and nature of these cells; their distinctive features; and their biological roles in cancer, infectious diseases, autoimmunity, obesity and pregnancy.

摘要

髓系来源的抑制细胞(MDSCs)是在多种病理条件下产生的异质性细胞群体,范围从癌症到肥胖。这些细胞代表单核细胞和相对不成熟的中性粒细胞活化的病理状态。MDSCs 的特征在于其独特的基因组和生化特征,并且可以根据最近的发现,通过特定的表面分子来区分。这些细胞的显著特征是它们抑制 T 细胞功能的能力,从而有助于各种疾病的发病机制。在这篇综述中,我们讨论了这些细胞的起源和性质;它们的独特特征;以及它们在癌症、传染病、自身免疫、肥胖和妊娠中的生物学作用。

相似文献

1
Myeloid-derived suppressor cells coming of age.髓系来源的抑制细胞崭露头角。
Nat Immunol. 2018 Feb;19(2):108-119. doi: 10.1038/s41590-017-0022-x. Epub 2018 Jan 18.
2
Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases.自身免疫性疾病中髓系来源抑制细胞的表型和功能多样性。
Mediators Inflamm. 2018 Dec 23;2018:4316584. doi: 10.1155/2018/4316584. eCollection 2018.
3
The immunobiology of myeloid-derived suppressor cells in cancer.癌症中髓源性抑制细胞的免疫生物学
Tumour Biol. 2016 Feb;37(2):1387-406. doi: 10.1007/s13277-015-4477-9. Epub 2015 Nov 26.
4
Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.人类疾病中的白细胞免疫球蛋白样受体:其分布、功能及免疫治疗潜在应用概述
J Leukoc Biol. 2017 Aug;102(2):351-360. doi: 10.1189/jlb.5MR1216-534R. Epub 2017 Mar 28.
5
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity.髓系来源抑制细胞:不仅仅在肿瘤免疫中。
Front Immunol. 2019 May 15;10:1099. doi: 10.3389/fimmu.2019.01099. eCollection 2019.
6
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.CD4 + T效应记忆细胞功能障碍与胶质母细胞瘤患者中粒细胞性髓源性抑制细胞的积累有关。
Neuro Oncol. 2016 Jun;18(6):807-18. doi: 10.1093/neuonc/nov280. Epub 2015 Nov 17.
7
Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype.条件培养基可诱导人血液单核细胞向单核细胞来源的髓系抑制细胞表型分化。
Cell Immunol. 2018 Jan;323:49-58. doi: 10.1016/j.cellimm.2017.10.014. Epub 2017 Oct 31.
8
Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.肿瘤性疾病中调控髓源性抑制细胞产生的机制
Cancer Immunol Immunother. 2017 Aug;66(8):989-996. doi: 10.1007/s00262-017-1963-5. Epub 2017 Feb 21.
9
Suppression of T cells by myeloid-derived suppressor cells in cancer.癌症中髓源性抑制细胞对T细胞的抑制作用。
Hum Immunol. 2017 Feb;78(2):113-119. doi: 10.1016/j.humimm.2016.12.001. Epub 2016 Dec 7.
10
Neutrophils as myeloid-derived suppressor cells.中性粒细胞作为髓源性抑制细胞。
Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12989. doi: 10.1111/eci.12989. Epub 2018 Aug 7.

引用本文的文献

1
Comprehensive pan-cancer analysis reveals ubiquitin-conjugating enzyme 2T as a potential biomarker for prognosis and cancer immunity.全面的泛癌分析揭示泛素结合酶2T作为一种潜在的预后和癌症免疫生物标志物。
Oncol Lett. 2025 Aug 20;30(5):491. doi: 10.3892/ol.2025.15237. eCollection 2025 Nov.
2
Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.抗程序性死亡蛋白1(Anti-PD-1)治疗反应与循环髓系细胞和T细胞亚群流入转移性黑色素瘤肿瘤微环境有关。
Br J Cancer. 2025 Sep 2. doi: 10.1038/s41416-025-03137-8.
3
Exploration of the Roles and Mechanisms Between Tumor-Infiltrating Lymphocytes and Hepatocellular Carcinoma Based on Single-Cell Transcriptomics.

本文引用的文献

1
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function.新型粒细胞-巨噬细胞集落刺激因子通过γ干扰素受体/干扰素调节因子-1和蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路赋予单核细胞抑制功能。
Blood Adv. 2017 Jun 7;1(14):947-960. doi: 10.1182/bloodadvances.2017006858. eCollection 2017 Jun 13.
2
Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment.肥胖对前列腺肿瘤微环境中巨噬细胞群体调节的影响。
Nutr Cancer. 2017 Oct;69(7):996-1002. doi: 10.1080/01635581.2017.1359320. Epub 2017 Sep 25.
3
Cancer-promoting mechanisms of tumor-associated neutrophils.
基于单细胞转录组学探究肿瘤浸润淋巴细胞与肝细胞癌之间的作用及机制
Int J Genomics. 2025 Aug 20;2025:1575734. doi: 10.1155/ijog/1575734. eCollection 2025.
4
Immunotherapy in Head and Neck Cancer.头颈部癌症的免疫疗法
Cancer Treat Res. 2025;129:119-156. doi: 10.1007/978-3-031-97242-3_7.
5
Mogat1 drives metabolic adaptations to evade immune surveillance.Mogat1驱动代谢适应性变化以逃避免疫监视。
Nat Commun. 2025 Jul 31;16(1):7035. doi: 10.1038/s41467-025-62134-w.
6
Molecular and genetic evidence for the role of AMBRA1 in suppressing S-phase entry and tumorigenesis.AMBRA1在抑制S期进入和肿瘤发生中作用的分子和遗传学证据。
iScience. 2025 Jul 5;28(8):113054. doi: 10.1016/j.isci.2025.113054. eCollection 2025 Aug 15.
7
Towards the development of next-generation lung cancer immunotherapy.迈向新一代肺癌免疫疗法的发展
Transl Lung Cancer Res. 2025 Jun 30;14(6):2257-2271. doi: 10.21037/tlcr-2024-1097. Epub 2025 Jun 25.
8
T cells in cancer: mechanistic insights and therapeutic advances.癌症中的T细胞:机制洞察与治疗进展
Biomark Res. 2025 Jul 15;13(1):97. doi: 10.1186/s40364-025-00807-w.
9
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
10
Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance.肿瘤微环境中的肿瘤驯化细胞:免疫治疗耐药性的关键驱动因素
Chin J Cancer Res. 2025 Jun 30;37(3):446-465. doi: 10.21147/j.issn.1000-9604.2025.03.12.
肿瘤相关中性粒细胞的促癌机制。
Am J Surg. 2017 Nov;214(5):938-944. doi: 10.1016/j.amjsurg.2017.08.003. Epub 2017 Aug 10.
4
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models.环磷酰胺对两种小鼠肿瘤模型中抗细胞毒性T淋巴细胞相关蛋白4阻断疗法的不同作用
Cancer Sci. 2017 Oct;108(10):1974-1984. doi: 10.1111/cas.13337. Epub 2017 Aug 29.
5
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF.肥胖改变肺部髓样细胞格局,通过白细胞介素5和粒细胞-巨噬细胞集落刺激因子增强乳腺癌转移。
Nat Cell Biol. 2017 Aug;19(8):974-987. doi: 10.1038/ncb3578. Epub 2017 Jul 24.
6
Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.癌症中小鼠与人类中性粒细胞的比较:一个重大的知识空白。
Trends Cancer. 2017 Feb;3(2):149-160. doi: 10.1016/j.trecan.2016.12.006. Epub 2017 Jan 19.
7
Macrophage functions in lean and obese adipose tissue.巨噬细胞在瘦型和肥胖型脂肪组织中的功能。
Metabolism. 2017 Jul;72:120-143. doi: 10.1016/j.metabol.2017.04.005. Epub 2017 Apr 18.
8
Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition.与原发性HIV感染疾病进展相关的髓源性抑制细胞:程序性死亡受体配体1阻断可减弱抑制作用。
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):200-208. doi: 10.1097/QAI.0000000000001471.
9
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).GM-CSF 与黑色素瘤肽疫苗接种在辅助治疗切除高危黑色素瘤随机试验中的免疫相关性(E4697 研究)。
Clin Cancer Res. 2017 Sep 1;23(17):5034-5043. doi: 10.1158/1078-0432.CCR-16-3016. Epub 2017 May 23.
10
Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli.新生儿髓源性抑制细胞在感染大肠埃希菌后凋亡减少,免疫抑制活性降低。
Eur J Immunol. 2017 Jun;47(6):1009-1021. doi: 10.1002/eji.201646621. Epub 2017 May 26.